Unlocking microbial dark matter: A biotechnology framework for replenishing the antibiotic pipeline.
The antibiotic pipeline is in crisis, even though microbial natural products, account for most approved antibacterial drugs and retain vast, untapped biosynthetic potential. Genuinely new scaffolds are rare because discovery remains constrained to a narrow set of cultivable taxa and expressed biosynthetic gene clusters...